Literature DB >> 11891027

A prospective study of a total material of lung cancer from a county in Sweden 1997-1999: gender, symptoms, type, stage, and smoking habits.

Hirsh Koyi1, Gunnar Hillerdal, Eva Brandén.   

Abstract

The epidemiology of lung cancer is changing in many parts of the world. In the industrialized countries, there is a trend that the incidence in men is declining, while it is increasing for women. Also, adenocarcinomas are becoming relatively more common, especially among men. The purpose of this study was to investigate whether such trends also occur in Sweden and also to describe other aspects of an unselected lung cancer material today, such as symptoms, stage and smoking habits. In the county of Gaevleborg, Sweden, practically all patients with lung cancer are referred to the lung department, and thus a total material of lung cancer patients with only a minimal selection bias can be studied. All patients with lung cancer in the county from January 1, 1997 to December 31, 1999, were investigated prospectively regarding stage, type of cancer, and symptoms. In all, there were 364 patients, 237 (65.1%) men and 127 (34.9%) women. The mean age for men was 69.8 and for women, 68.1 years. 91.9% of the men and 78.6% of the women were smokers or ex-smokers. In general the men were heavier smokers than were the women (P<0.0001). Adenocarcinoma was the most common subtype found in women and squamous cell carcinoma in men. The excess of adenocarcinoma in women was due to never-smoking women; for smoking and ex-smoking men and women, the proportion of adenocarcinomas was the same. In all, 240 patients (68.0%) were diagnosed at Stage IIIb (27.2%) or IV (40.8%), with no significant differences between the sexes. The most common first symptom was cough. Only 7.0% of patients were asymptomatic. In conclusion, the trend of an increasing proportion of adenocarcinoma in lung cancer is seen also in Sweden. A depressingly high percentage of patients present in late stages and are thus inoperable.

Entities:  

Mesh:

Year:  2002        PMID: 11891027     DOI: 10.1016/s0169-5002(01)00451-2

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.

Authors:  Matthew D Wilkerson; Xiaoying Yin; Katherine A Hoadley; Yufeng Liu; Michele C Hayward; Christopher R Cabanski; Kenneth Muldrew; C Ryan Miller; Scott H Randell; Mark A Socinski; Alden M Parsons; William K Funkhouser; Carrie B Lee; Patrick J Roberts; Leigh Thorne; Philip S Bernard; Charles M Perou; D Neil Hayes
Journal:  Clin Cancer Res       Date:  2010-07-19       Impact factor: 12.531

2.  Non-AIDS-Defining Cancers and HIV Infection.

Authors:  Soon Thye Lim; Alexandra M Levine
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

Review 3.  Non-AIDS-defining cancers and HIV infection.

Authors:  Soon Thye Lim; Alexandra M Levine
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

4.  What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.

Authors:  W Hamilton; T J Peters; A Round; D Sharp
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

5.  Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.

Authors:  Madeline Vazquez; Darryl Carter; Elizabeth Brambilla; Adi Gazdar; Masayuki Noguchi; William D Travis; Yao Huang; Lijuan Zhang; Rowena Yip; David F Yankelevitz; Claudia I Henschke
Journal:  Lung Cancer       Date:  2008-10-31       Impact factor: 5.705

6.  Occupation, gender, race, and lung cancer.

Authors:  Sania Amr; Beverly Wolpert; Christopher A Loffredo; Yun-Ling Zheng; Peter G Shields; Raymond Jones; Curtis C Harris
Journal:  J Occup Environ Med       Date:  2008-10       Impact factor: 2.162

7.  Biopsy testing in an inoperable, non-small cell lung cancer population-a retrospective, real-life study in Sweden.

Authors:  Hirsh Koyi; Leif Johansson; Jesper From; Sven Nyrén
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

8.  DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.

Authors:  Suhaida A Selamat; Janice S Galler; Amit D Joshi; M Nicky Fyfe; Mihaela Campan; Kimberly D Siegmund; Keith M Kerr; Ite A Laird-Offringa
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

9.  Initial medical attention on patients with early-stage non-small cell lung cancer.

Authors:  Xing Chen; Ivan P Gorlov; Jun Ying; Kelly W Merriman; Marek Kimmel; Charles Lu; Cielito C Reyes-Gibby; Olga Y Gorlova
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

10.  Non-small-cell lung cancer in a French department, (1982-1997): management and outcome.

Authors:  J Foeglé; G Hédelin; M P Lebitasy; A Purohit; M Velten; E Quoix
Journal:  Br J Cancer       Date:  2005-02-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.